The cited 2023 pioneer study additionally showed that CHI3L1 serves as a TAN chemoattractant [51], which in turn reduces TAN(-precursor) infiltration in the primary tumor and promotes T-cell exclusion in the TME through formation of NETs. The gene discussed is CHI3L1; the disease is neoplasm.